Action
EGFR
Alt Name
Portrazza
IMC-11F8
Approval Jurisdiction
2015 FDA 2015 EMA
Approved for clinical use
NSCLC
CAS
906805-06-9
Commercial Vendor
Eli Lilly
Compound Image
Necitumumab.png
Compound name
Necitumumab
Reference
Reference 2
Approved Drug List
1